Cushla and Clirinx, two Irish startups, are merging to give rare disease patients one continuous health and research record. The deal will pair Cushla’s patient-controlled EHR with Clirinx’s unique patient ID system so data no longer gets lost between doctors, hospitals and clinical trials.
The post This Merger Wants to Prevent Rare Disease Patients from Losing Their Data appeared first on MedCity News.
